Search results
Results from the WOW.Com Content Network
The law took effect on June 22, 2002, 15 days after it was signed by Gloria Macapagal Arroyo.Its primary implementing agency is the Philippine Drug Enforcement Agency.The list of illegal drugs may be modified by the DDB through a proceeding initiated by the PDEA, the Department of Health, or any petition by a concerned party.
The drug policy of the Philippines is guided by the Comprehensive Dangerous Drugs Act of 2002 and is implemented by the Dangerous Drugs Board with its implementing arm, the Philippine Drug Enforcement Agency along with other member agencies. Aside from regulating and prohibiting the usage, sale, production of certain drugs, the 2002 law is ...
At the time when the Republic Act 6425, also known as the Dangerous Drugs Act of 1972, was approved on March 30, 1972, there were 20,000 drug users and marijuana was the most preferred illegal drug among users in the country.
For thirty years, the Republic Act No. 6425, or the Dangerous Drugs Act of 1972, had been the backbone of the drug law enforcement system in the Philippines. Despite the efforts of various law enforcement agencies mandated to implement the law, the drug problem alarmingly escalated with orbiting Police Officers collecting drug money.
Year of discovery Name of the drug Year when the synthesis mechanism was developed Year that was Patented Governmental approval Patented expired 1901: Adrenaline: Jōkichi Takamine, 1901: 1901: 1901: N/A (Natural Hormone) 1906: Oxytocin: Discovered by Henry Hallett Dale, synthesized by Vincent du Vigneaud in 1952: 1925: 1926: N/A (Natural ...
A Philippine court has dropped drugs charges against one of the most vocal critics of former President Rodrigo Duterte’s bloody “war on drugs,” ending a long legal battle that had seen the ...
The Philippine Senate Committee on Public Order and Dangerous Drugs is a standing committee of the Senate of the Philippines. It was known as the Committee on Public Order and Illegal Drugs until November 9, 2010.
Frances Arnold, who won the chemistry Nobel Prize in 2018 and sits on Iambic's board, told Reuters the development represented a major advance in the use of AI for drug discovery.